ProPhase Labs to Present at the H.C. Wainwright 2022 Global Investment Conference
May 18, 2022 08:15 ET
|
ProPhase Labs, Inc.
May 23-26, 2022 (HYBRID CONFERENCE) Garden City, NY, May 18, 2022 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a diversified diagnostics and genomics company, today announced that...
ProPhase Labs to Present at the Planet MicroCap Showcase 2022 on Wednesday, May 4, 2022
April 27, 2022 08:15 ET
|
ProPhase Labs, Inc.
Garden City, NY, April 27, 2022 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a diversified diagnostics and genomics company, today announced that Chairman and CEO Ted Karkus will present...
ProPhase Labs Continues to Build Strong Leadership with Key Promotions and Additions to Management Team
December 16, 2021 08:30 ET
|
ProPhase Labs, Inc.
Precision Medicine division adds Industry Veteran Sam A. Beeler as Chief Strategy Officer; Diagnostics Division Promotes Alice Lioi and Jason Karkus to EVP and Co-Chief Operating Officers and Sergio...
ProPhase Labs Partners With Dutchess County New York to Provide COVID-19 Testing
May 06, 2021 08:30 ET
|
ProPhase Labs, Inc.
State-Of-The-Art COVID-19 Testing Available for 300,000 Residents to Aid Reopening Efforts GARDEN CITY, NY, May 06, 2021 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (Nasdaq: PRPH), a diversified...